Safetek International Inc. Executes Term Sheet Regarding Licensing Rights For A Drug Candidate Targeting Degenerative Diseases
4/24/2006 10:36:29 AM
More...
|
Safetek International Inc. To Develop Novel Selective Muscarinic Receptor Antagonist For Over Active Bladder
4/11/2006 11:09:22 AM
More...
|
Safetek International Inc. Acquires International Licensing Option Rights For A Novel Drug Candidate
1/11/2006 10:53:45 AM
More...
|